id	sid	eid	entity	type
ajlm-1809	1	1	tygerberg hospital	ORG
ajlm-1809	1	2	tygerberg	GPE
ajlm-1809	1	3	south africa	GPE
ajlm-1809	1	4	stellenbosch university	ORG
ajlm-1809	1	5	cape town	GPE
ajlm-1809	1	6	south africa	GPE
ajlm-1809	1	7	mae	PERSON
ajlm-1809	1	8	national health laboratory service	ORG
ajlm-1809	1	9	tygerberg hospital	ORG
ajlm-1809	1	10	tygerberg	GPE
ajlm-1809	1	11	south africa	GPE
ajlm-1809	1	12	stellenbosch university	ORG
ajlm-1809	1	13	cape town	GPE
ajlm-1809	1	14	south africa	GPE
ajlm-1809	1	15	pieter nel national health laboratory service	ORG
ajlm-1809	1	16	tygerberg hospital	ORG
ajlm-1809	1	17	tygerberg	GPE
ajlm-1809	1	18	south africa	GPE
ajlm-1809	1	19	stellenbosch university	ORG
ajlm-1809	1	20	cape town	GPE
ajlm-1809	1	21	south africa	GPE
ajlm-1809	1	22	tygerberg hospital	ORG
ajlm-1809	1	23	tygerberg	GPE
ajlm-1809	1	24	south africa	GPE
ajlm-1809	1	25	stellenbosch university	ORG
ajlm-1809	1	26	cape town	GPE
ajlm-1809	1	27	south africa	GPE
ajlm-1809	1	28	singh s	ORG
ajlm-1809	1	29	newton	ORG
ajlm-1809	1	30	pienaar c.	PERSON
ajlm-1809	1	31	two	CARDINAL
ajlm-1809	1	32	south africa	GPE
ajlm-1809	2	1	afr j	PERSON
ajlm-1809	3	1	2022;11(1	CARDINAL
ajlm-1809	3	2	a1809.	ORG
ajlm-1809	4	1	two	CARDINAL
ajlm-1809	4	2	south africa sarishna	GPE
ajlm-1809	4	3	singh	GPE
ajlm-1809	4	4	mae newton-foot	PERSON
ajlm-1809	4	5	pieter nel	PERSON
ajlm-1809	4	6	colette pienaar	PERSON
ajlm-1809	4	7	03	CARDINAL
ajlm-1809	4	8	dec. 2021	DATE
ajlm-1809	4	9	26	CARDINAL
ajlm-1809	4	10	2022	CARDINAL
ajlm-1809	4	11	29	CARDINAL
ajlm-1809	4	12	2022	CARDINAL
ajlm-1809	4	13	2022	CARDINAL
ajlm-1809	11	1	three	CARDINAL
ajlm-1809	11	2	two	CARDINAL
ajlm-1809	12	1	two hundred and twenty-three	CARDINAL
ajlm-1809	12	2	the national health laboratory service microbiology	ORG
ajlm-1809	12	3	tygerberg hospital	ORG
ajlm-1809	12	4	cape town	GPE
ajlm-1809	12	5	south africa	GPE
ajlm-1809	12	6	october 2017 to october 2018	DATE
ajlm-1809	13	1	two	CARDINAL
ajlm-1809	13	2	xpert c. difficile	PERSON
ajlm-1809	13	3	max cdiff	PERSON
ajlm-1809	14	1	two	CARDINAL
ajlm-1809	14	2	xpert c. difficile	PERSON
ajlm-1809	15	1	223	CARDINAL
ajlm-1809	15	2	37	DATE
ajlm-1809	15	3	16.6%	PERCENT
ajlm-1809	16	1	54.1%	PERCENT
ajlm-1809	16	2	98.9%	PERCENT
ajlm-1809	16	3	xpert c. difficile	PERSON
ajlm-1809	16	4	86.4%	PERCENT
ajlm-1809	16	5	96.8%	PERCENT
ajlm-1809	16	6	max cdiff	PERSON
ajlm-1809	16	7	89.2%	PERCENT
ajlm-1809	16	8	96.8%	PERCENT
ajlm-1809	16	9	two	CARDINAL
ajlm-1809	16	10	89.2%	PERCENT
ajlm-1809	16	11	96.2%	PERCENT
ajlm-1809	17	1	two	CARDINAL
ajlm-1809	17	2	xpert c. difficile	PERSON
ajlm-1809	18	1	xpert	PERSON
ajlm-1809	18	2	max	PERSON
ajlm-1809	20	1	up to 20%	PERCENT
ajlm-1809	20	2	south africa	GPE
ajlm-1809	20	3	16%.3	CARDINAL
ajlm-1809	20	4	the past two decades	DATE
ajlm-1809	20	5	two	CARDINAL
ajlm-1809	21	1	north america	LOC
ajlm-1809	21	2	027/nap1/bi	ORG
ajlm-1809	21	3	cdta	PERSON
ajlm-1809	23	1	two	CARDINAL
ajlm-1809	23	2	2–3	CARDINAL
ajlm-1809	23	3	two	CARDINAL
ajlm-1809	26	1	techlab	NORP
ajlm-1809	26	2	blacksburg	GPE
ajlm-1809	26	3	virginia	GPE
ajlm-1809	26	4	united states	GPE
ajlm-1809	26	5	two	CARDINAL
ajlm-1809	26	6	xpert c. difficile	PERSON
ajlm-1809	26	7	xpert	PERSON
ajlm-1809	26	8	cepheid	ORG
ajlm-1809	26	9	sunnyvale	GPE
ajlm-1809	26	10	california	GPE
ajlm-1809	26	11	united states	GPE
ajlm-1809	26	12	max	PERSON
ajlm-1809	26	13	becton dickinson	PERSON
ajlm-1809	26	14	san jose	GPE
ajlm-1809	26	15	california	GPE
ajlm-1809	26	16	united states	GPE
ajlm-1809	27	1	two	CARDINAL
ajlm-1809	27	2	xpert	PERSON
ajlm-1809	28	1	the health research ethics committee of stellenbosch university	ORG
ajlm-1809	28	2	cape town	GPE
ajlm-1809	28	3	south africa	GPE
ajlm-1809	32	1	three	CARDINAL
ajlm-1809	32	2	xpert	PERSON
ajlm-1809	33	1	two	CARDINAL
ajlm-1809	33	2	xpert	PERSON
ajlm-1809	34	1	crs	ORG
ajlm-1809	34	2	two	CARDINAL
ajlm-1809	35	1	tygerberg hospital	ORG
ajlm-1809	35	2	cape town	GPE
ajlm-1809	35	3	south africa	GPE
ajlm-1809	35	4	1380	CARDINAL
ajlm-1809	35	5	approximately half	CARDINAL
ajlm-1809	35	6	6.2 million	CARDINAL
ajlm-1809	36	1	the national health laboratory service	ORG
ajlm-1809	36	2	tygerberg hospital	ORG
ajlm-1809	37	1	16%	PERCENT
ajlm-1809	37	2	95%	PERCENT
ajlm-1809	37	3	5%	PERCENT
ajlm-1809	37	4	207	CARDINAL
ajlm-1809	37	5	g dean & km sullivan	ORG
ajlm-1809	37	6	atlanta	GPE
ajlm-1809	37	7	georgia	GPE
ajlm-1809	37	8	united	ORG
ajlm-1809	37	9	older than two years of age	DATE
ajlm-1809	37	10	the national health laboratory service microbiology	ORG
ajlm-1809	37	11	tygerberg hospital	ORG
ajlm-1809	37	12	october 2017 to october 2018	DATE
ajlm-1809	37	13	four	CARDINAL
ajlm-1809	39	1	the day	DATE
ajlm-1809	39	2	2 °	QUANTITY
ajlm-1809	39	3	8 °	QUANTITY
ajlm-1809	39	4	48	DATE
ajlm-1809	42	1	xpert	PERSON
ajlm-1809	51	1	two	CARDINAL
ajlm-1809	52	1	xpert	PERSON
ajlm-1809	53	1	chromid c.diff	DATE
ajlm-1809	53	2	biomérieux	ORG
ajlm-1809	53	3	france	GPE
ajlm-1809	55	1	mitsubishi gas chemical company, inc.	ORG
ajlm-1809	55	2	tokyo	GPE
ajlm-1809	55	3	japan	GPE
ajlm-1809	55	4	35 ºc	CARDINAL
ajlm-1809	56	1	48	DATE
ajlm-1809	57	1	multiplex	NORP
ajlm-1809	58	1	only.18	ORG
ajlm-1809	58	2	2000	CARDINAL
ajlm-1809	58	3	1.00	CARDINAL
ajlm-1809	58	4	london	GPE
ajlm-1809	58	5	england	GPE
ajlm-1809	59	1	223	CARDINAL
ajlm-1809	60	1	37	DATE
ajlm-1809	60	2	16.6%	PERCENT
ajlm-1809	60	3	19/37	CARDINAL
ajlm-1809	60	4	51.4%	PERCENT
ajlm-1809	60	5	three	CARDINAL
ajlm-1809	61	1	17.9%	PERCENT
ajlm-1809	62	1	45/223	CARDINAL
ajlm-1809	62	2	20.2%	PERCENT
ajlm-1809	63	1	twenty-two	CARDINAL
ajlm-1809	63	2	45	CARDINAL
ajlm-1809	63	3	48.9%	PERCENT
ajlm-1809	63	4	20/22	CARDINAL
ajlm-1809	63	5	91%	PERCENT
ajlm-1809	64	1	23	CARDINAL
ajlm-1809	64	2	11	DATE
ajlm-1809	64	3	47.8%	PERCENT
ajlm-1809	64	4	1	CARDINAL
ajlm-1809	65	1	1	CARDINAL
ajlm-1809	65	2	the national health laboratory service microbiology	ORG
ajlm-1809	65	3	tygerberg hospital	ORG
ajlm-1809	65	4	cape town	GPE
ajlm-1809	65	5	south africa	GPE
ajlm-1809	65	6	october 2017 to	DATE
ajlm-1809	65	7	223	CARDINAL
ajlm-1809	65	8	17%	PERCENT
ajlm-1809	65	9	xpert	PERSON
ajlm-1809	65	10	32/38	CARDINAL
ajlm-1809	65	11	84.2%	PERCENT
ajlm-1809	66	1	027/nap1/bi	ORG
ajlm-1809	67	1	185	CARDINAL
ajlm-1809	67	2	180	CARDINAL
ajlm-1809	67	3	97.3%	PERCENT
ajlm-1809	67	4	5/185	CARDINAL
ajlm-1809	67	5	2.7%	PERCENT
ajlm-1809	67	6	xpert	PERSON
ajlm-1809	67	7	1	CARDINAL
ajlm-1809	68	1	39/223	CARDINAL
ajlm-1809	68	2	17.5%	PERCENT
ajlm-1809	68	3	33/39	CARDINAL
ajlm-1809	68	4	84.6%	PERCENT
ajlm-1809	68	5	tc	ORG
ajlm-1809	68	6	one hundred and eighty	CARDINAL
ajlm-1809	68	7	184	CARDINAL
ajlm-1809	68	8	97.8%	PERCENT
ajlm-1809	68	9	2.2%	PERCENT
ajlm-1809	69	1	two	CARDINAL
ajlm-1809	69	2	40	CARDINAL
ajlm-1809	69	3	33	DATE
ajlm-1809	69	4	82.5%	PERCENT
ajlm-1809	69	5	183	CARDINAL
ajlm-1809	69	6	179	CARDINAL
ajlm-1809	69	7	97.8%	PERCENT
ajlm-1809	69	8	1	CARDINAL
ajlm-1809	70	1	xpert	PERSON
ajlm-1809	70	2	two	CARDINAL
ajlm-1809	70	3	npv	ORG
ajlm-1809	70	4	crs	PRODUCT
ajlm-1809	70	5	1	CARDINAL
ajlm-1809	71	1	xpert	PERSON
ajlm-1809	71	2	two	CARDINAL
ajlm-1809	71	3	crs	ORG
ajlm-1809	72	1	c. difficile laboratory assays	PERSON
ajlm-1809	73	1	two	CARDINAL
ajlm-1809	73	2	crs	ORG
ajlm-1809	74	1	three	CARDINAL
ajlm-1809	75	1	54.1%	PERCENT
ajlm-1809	75	2	xpert	PERSON
ajlm-1809	75	3	86.4%	PERCENT
ajlm-1809	75	4	89.2%	PERCENT
ajlm-1809	75	5	two	CARDINAL
ajlm-1809	75	6	89.2%	PERCENT
ajlm-1809	76	1	98.9%	PERCENT
ajlm-1809	76	2	xpert	PERSON
ajlm-1809	76	3	96.8%	PERCENT
ajlm-1809	76	4	96.8%	PERCENT
ajlm-1809	76	5	two	CARDINAL
ajlm-1809	76	6	96.2%	PERCENT
ajlm-1809	77	1	90.9%	PERCENT
ajlm-1809	77	2	xpert	PERSON
ajlm-1809	77	3	84.2%	PERCENT
ajlm-1809	77	4	84.6%	PERCENT
ajlm-1809	77	5	two	CARDINAL
ajlm-1809	77	6	82.5%	PERCENT
ajlm-1809	78	1	npv	ORG
ajlm-1809	78	2	91.5%	PERCENT
ajlm-1809	78	3	xpert	PERSON
ajlm-1809	78	4	97.3%	PERCENT
ajlm-1809	78	5	97.8%	PERCENT
ajlm-1809	78	6	two	CARDINAL
ajlm-1809	78	7	97.2%	PERCENT
ajlm-1809	82	1	first	ORDINAL
ajlm-1809	82	2	two	CARDINAL
ajlm-1809	82	3	three	CARDINAL
ajlm-1809	82	4	54.1%	PERCENT
ajlm-1809	82	5	98.9%	PERCENT
ajlm-1809	82	6	90.9%	PERCENT
ajlm-1809	82	7	91.5%	PERCENT
ajlm-1809	83	1	2012	DATE
ajlm-1809	83	2	kuwait	GPE
ajlm-1809	83	3	xpert	PERSON
ajlm-1809	83	4	53.85%	PERCENT
ajlm-1809	83	5	100%	PERCENT
ajlm-1809	83	6	100%	PERCENT
ajlm-1809	83	7	98.51%	PERCENT
ajlm-1809	83	8	two	CARDINAL
ajlm-1809	83	9	agreement.19	GPE
ajlm-1809	83	10	2009–2018	CARDINAL
ajlm-1809	83	11	chung	ORG
ajlm-1809	83	12	lee	PERSON
ajlm-1809	83	13	korea	GPE
ajlm-1809	83	14	xpert	PERSON
ajlm-1809	83	15	55.4%	PERCENT
ajlm-1809	83	16	100.0%	PERCENT
ajlm-1809	83	17	100.0%	PERCENT
ajlm-1809	83	18	80.0%	PERCENT
ajlm-1809	83	19	35.9%	PERCENT
ajlm-1809	83	20	16.6%	PERCENT
ajlm-1809	83	21	100.0%	PERCENT
ajlm-1809	83	22	2013–2014	CARDINAL
ajlm-1809	84	1	korea	GPE
ajlm-1809	84	2	45.7%	PERCENT
ajlm-1809	84	3	xpert	PERSON
ajlm-1809	84	4	77% to 100%	PERCENT
ajlm-1809	85	1	83% to 100%	PERCENT
ajlm-1809	85	2	2019	DATE
ajlm-1809	85	3	94%	PERCENT
ajlm-1809	85	4	97%	PERCENT
ajlm-1809	85	5	xpert	PERSON
ajlm-1809	85	6	86.4%	PERCENT
ajlm-1809	85	7	96.8%	PERCENT
ajlm-1809	85	8	84.2%	PERCENT
ajlm-1809	85	9	97.3%	PERCENT
ajlm-1809	85	10	89.2%	PERCENT
ajlm-1809	85	11	96.8%	PERCENT
ajlm-1809	85	12	84.6%	PERCENT
ajlm-1809	85	13	97.8%	PERCENT
ajlm-1809	86	1	yoo et al.	PERSON
ajlm-1809	87	1	korea	GPE
ajlm-1809	87	2	82.8%	PERCENT
ajlm-1809	87	3	xpert	PERSON
ajlm-1809	87	4	81.6%	PERCENT
ajlm-1809	88	1	two	CARDINAL
ajlm-1809	88	2	germany	GPE
ajlm-1809	88	3	97.3%	PERCENT
ajlm-1809	88	4	97.9%	PERCENT
ajlm-1809	88	5	90.0%	PERCENT
ajlm-1809	88	6	99.5%	PERCENT
ajlm-1809	88	7	xpert	PERSON
ajlm-1809	88	8	90.5%	PERCENT
ajlm-1809	88	9	97.9%	PERCENT
ajlm-1809	88	10	89.3%	PERCENT
ajlm-1809	88	11	98.1%	PERCENT
ajlm-1809	88	12	2014–2017	CARDINAL
ajlm-1809	88	13	south africa	GPE
ajlm-1809	88	14	15.9%	PERCENT
ajlm-1809	88	15	11.4%	PERCENT
ajlm-1809	88	16	21.1%	PERCENT
ajlm-1809	88	17	two	CARDINAL
ajlm-1809	89	1	16.6%	PERCENT
ajlm-1809	89	2	89.2%	PERCENT
ajlm-1809	89	3	96.2%	PERCENT
ajlm-1809	89	4	two	CARDINAL
ajlm-1809	90	1	89.0%	PERCENT
ajlm-1809	90	2	99.0%	PERCENT
ajlm-1809	90	3	assay.10	PRODUCT
ajlm-1809	90	4	94.0%	PERCENT
ajlm-1809	90	5	100.0%	PERCENT
ajlm-1809	90	6	100.0%	PERCENT
ajlm-1809	90	7	100.0%	PERCENT
ajlm-1809	90	8	two	CARDINAL
ajlm-1809	90	9	xpert	PERSON
ajlm-1809	90	10	npv	ORG
ajlm-1809	91	1	xpert	PERSON
ajlm-1809	91	2	two	CARDINAL
ajlm-1809	91	3	crs	PRODUCT
ajlm-1809	92	1	xpert	PERSON
ajlm-1809	92	2	two	CARDINAL
ajlm-1809	98	1	xpert	PERSON
ajlm-1809	98	2	two	CARDINAL
ajlm-1809	99	1	two	CARDINAL
ajlm-1809	99	2	xpert	PERSON
ajlm-1809	100	1	two	CARDINAL
ajlm-1809	100	2	south africa	GPE
ajlm-1809	101	1	dr motlatji maloba	PERSON
ajlm-1809	101	2	national health laboratory service	ORG
ajlm-1809	101	3	bloemfontein	GPE
ajlm-1809	101	4	south africa	GPE
ajlm-1809	101	5	brian kullin	PERSON
ajlm-1809	101	6	university of cape town	ORG
ajlm-1809	101	7	south africa	GPE
ajlm-1809	101	8	stellenbosch university	ORG
ajlm-1809	101	9	south africa	GPE
ajlm-1809	104	1	m.n.-f	DATE
ajlm-1809	105	1	p.n.	PERSON
ajlm-1809	106	1	c.p.	GPE
ajlm-1809	106	2	c.p.	ORG
ajlm-1809	108	1	the national health laboratory service	ORG
ajlm-1809	109	1	s.s.	PERSON
ajlm-1809	111	1	carroll kc	PERSON
ajlm-1809	112	1	clin microbiol	ORG
ajlm-1809	113	1	2013;26(3):604–630	CARDINAL
ajlm-1809	114	1	aronoff dm.	PERSON
ajlm-1809	116	1	2013;26(5):464–475	CARDINAL
ajlm-1809	116	2	kullin	GPE
ajlm-1809	116	3	d’alton j	GPE
ajlm-1809	117	1	schuur hospital	ORG
ajlm-1809	117	2	cape town	GPE
ajlm-1809	117	3	south africa	GPE
ajlm-1809	120	1	a. clostridium difficile infection	PERSON
ajlm-1809	120	2	the twenty-first century	DATE
ajlm-1809	122	1	2016;62(2):198–207	CARDINAL
ajlm-1809	123	1	pepin j	PERSON
ajlm-1809	123	2	north america	LOC
ajlm-1809	123	3	europe	LOC
ajlm-1809	124	1	lancet	ORG
ajlm-1809	125	1	2005;366(9491):1079–1084	CARDINAL
ajlm-1809	126	1	tüll p	ORG
ajlm-1809	126	2	north america	LOC
ajlm-1809	126	3	europe	LOC
ajlm-1809	127	1	clin microbiol	ORG
ajlm-1809	128	1	2006;12(suppl 6):2–18	DATE
ajlm-1809	129	1	di bella s	PERSON
ajlm-1809	129	2	siarakas s	ORG
ajlm-1809	129	3	di masi a. clostridium difficile toxins	PERSON
ajlm-1809	131	1	2016;8(5):134	TIME
ajlm-1809	132	1	https://doi.org/10.3390/toxins8050134 berry ce	PERSON
ajlm-1809	132	2	davies ka	PERSON
ajlm-1809	132	3	owens dw	PERSON
ajlm-1809	132	4	wilcox mh	PERSON
ajlm-1809	132	5	cdi	ORG
ajlm-1809	133	1	j clin microbiol	PERSON
ajlm-1809	135	1	https://doi.org/10.1007/s10096-017-3075-8 gerding dn	PERSON
ajlm-1809	135	2	johnson s	PERSON
ajlm-1809	135	3	k. clostridium difficile binary	PERSON
ajlm-1809	135	4	cdt	GPE
ajlm-1809	138	1	2014;5(1):15–27	DATE
ajlm-1809	139	1	parrott	PERSON
ajlm-1809	139	2	cornish ne	PERSON
ajlm-1809	141	1	clin microbiol	ORG
ajlm-1809	142	1	2019;32(3):e00032-18	DATE
ajlm-1809	143	1	mcdonald lc	PERSON
ajlm-1809	143	2	johnson s	PERSON
ajlm-1809	144	1	2017	CARDINAL
ajlm-1809	144	2	america	GPE
ajlm-1809	145	1	clin infect dis	ORG
ajlm-1809	146	1	2018;66(7):987–994. https://doi.org/10.1093/cid/ciy149 tang s	TIME
ajlm-1809	146	2	hemyari p	ORG
ajlm-1809	146	3	canchola ja	PERSON
ajlm-1809	146	4	duncan j.	PERSON
ajlm-1809	148	1	2018;28(5):951–965	CARDINAL
ajlm-1809	149	1	https://doi.org/10.1080/10543406.2018.1428613	ORG
ajlm-1809	151	1	3.01	CARDINAL
ajlm-1809	152	1	2013	DATE
ajlm-1809	153	1	2021	CARDINAL
ajlm-1809	154	1	https://www.openepi.com/menu/oe_menu.htm	ORG
ajlm-1809	154	2	wilcox m.	PERSON
ajlm-1809	154	3	one	CARDINAL
ajlm-1809	154	4	two	CARDINAL
ajlm-1809	155	1	j clin	PERSON
ajlm-1809	156	1	2011;64(1):1–5	CARDINAL
ajlm-1809	157	1	https://doi.org/10.1136/jcp.2010.080135 oldfield ec	PERSON
ajlm-1809	157	2	oldfield ec iii	PERSON
ajlm-1809	157	3	johnson da	PERSON
ajlm-1809	159	1	j gastrointest pharmacol	PERSON
ajlm-1809	160	1	2014;5(1):1–26	CARDINAL
ajlm-1809	161	1	eckert	PERSON
ajlm-1809	162	1	j clin microbiol	PERSON
ajlm-1809	163	1	2013;51(3):1002–1004	TIME
ajlm-1809	164	1	https://doi.org/10.1128/jcm.02601-12 lemee l	PERSON
ajlm-1809	165	1	multiplex	NORP
ajlm-1809	166	1	j clin microbiol	PERSON
ajlm-1809	167	1	2004;42(12):5710–5714	CARDINAL
ajlm-1809	168	1	a. clostridium difficile	PERSON
ajlm-1809	170	1	2012;4(2):149–158	CARDINAL
ajlm-1809	170	2	jamal w	PERSON
ajlm-1809	170	3	c.	PERSON
ajlm-1809	170	4	chek complete kit	ORG
ajlm-1809	173	1	https://doi.org/10.1016/j.ijid.2014.10.025 chung hs	PERSON
ajlm-1809	173	2	lee m.	PERSON
ajlm-1809	175	1	2017;65(1):88–92	CARDINAL
ajlm-1809	176	1	jeong jh	PERSON
ajlm-1809	176	2	kim kh	PERSON
ajlm-1809	176	3	ahn jy	PERSON
ajlm-1809	176	4	techlab c. diff	ORG
ajlm-1809	176	5	xpert c. difficile	PERSON
ajlm-1809	177	1	j clin	PERSON
ajlm-1809	178	1	tenover fc	PERSON
ajlm-1809	178	2	peterson lr	PERSON
ajlm-1809	180	1	j mol diagn	PERSON
ajlm-1809	181	1	2011;13(6):573–582	CARDINAL
ajlm-1809	181	2	mjt	DATE
ajlm-1809	183	1	2018;1050:27–44	CARDINAL
ajlm-1809	183	2	chung hs	PERSON
ajlm-1809	183	3	first	ORDINAL
ajlm-1809	183	4	korea	GPE
ajlm-1809	184	1	ann	PERSON
ajlm-1809	185	1	2021;41(2):171–180	CARDINAL
ajlm-1809	187	1	lee h	PERSON
ajlm-1809	187	2	lee gd	PERSON
ajlm-1809	187	3	park yg	PERSON
ajlm-1809	187	4	park yj	PERSON
ajlm-1809	187	5	3	CARDINAL
ajlm-1809	187	6	xpert c. difficile assay	PERSON
ajlm-1809	187	7	max cdiff	PERSON
ajlm-1809	187	8	c. difficile	PERSON
ajlm-1809	187	9	abbott m2000 assay	ORG
ajlm-1809	189	1	2015;83(1):7–10	PERSON
ajlm-1809	190	1	hofko m	PERSON
ajlm-1809	190	2	zorn m	ORG
ajlm-1809	190	3	zimmermann s. evaluation	PERSON
ajlm-1809	190	4	max cdiff	PERSON
ajlm-1809	190	5	xpert c. difficile assays	PERSON
ajlm-1809	191	1	j clin microbiol	PERSON
ajlm-1809	194	1	j. 2020;110(2):135–139	PERSON